RI HB 7187
deadAN ACT RELATING TO INSURANCE -- BENEFIT DETERMINATION AND UTILIZATION REVIEW ACT
Rhode Island · 2026 Regular Session · lower
Description
Prohibits healthcare insurers from requiring or conducting a review for prescription medicine used to treat alcohol or opioid use disorder containing Methadone, Burenorphine, or Naltrexone, or approved to mitigate opioid withdrawal symptoms.
- Introduced
- 2026-01-21
- Status date
- —
- Latest action
- 2026-02-03 — 02/03/2026 Committee recommended measure be held for further study
- Bill type
- bill
- Last updated
- —
Sponsors
- Casimiroprimary
- Fogartyprimary
- Carsonprimary
- Potterprimary
- Bennettprimary
- Edwardsprimary
Committees
Not provided by source.
Action timeline
2026-01-21
01/21/2026 Introduced, referred to House Health & Human Services
introduction,referral-committee
2026-01-30
01/30/2026 Scheduled for hearing and/or consideration (02/03/2026)
2026-02-03
02/03/2026 Committee recommended measure be held for further study
committee-failure
Versions
- 7187Compare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:31:46.990152Z
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=RI&identifier=HB 7187. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.